
Ra Pharmaceuticals
Ra Pharma is developing Cyclomimetics™, a new drug class combining the properties and benefits of antibodies and small molecules.
Employees
Enterprise value
$2.3b
Authorizing premium user...
Ra Pharma is developing Cyclomimetics™, a new drug class combining the properties and benefits of antibodies and small molecules.